Adam Hughes

Adam Hughes has extensive work experience in the field of medicinal chemistry. Adam is currently serving as the VP Medicinal Chemistry at Vicinitas Therapeutics since November 2022. Prior to this, they worked at Terray Therapeutics as the Head of Chemistry from December 2021 to November 2022. At Terray Therapeutics, they led the chemistry department and contributed to the development of novel therapies using artificial intelligence and nanotechnology.

Before joining Terray Therapeutics, Adam held multiple roles at Theravance Biopharma US, Inc. Adam served as the Executive Director of Medicinal Chemistry from June 2014 to November 2021. As a project and medicinal chemistry leader, they played a key role in the research and development of therapeutic compounds. Prior to that, they were an Associate Director of Medicinal Chemistry at Theravance Biopharma from November 2000 to June 2014.

Adam's career began at Stanford University, where they worked as a Post Doctoral Researcher from January 1999 to September 2000. Adam conducted research in the field of medicinal chemistry during this time. Adam completed their Ph.D. at the University of Nottingham, where they worked as a Ph.D. student from September 1995 to December 1998.

Overall, Adam Hughes has accumulated a wealth of experience in the pharmaceutical industry, particularly in medicinal chemistry. Adam'sexpertise and leadership have contributed to the development of innovative therapies throughout their career.

Adam Hughes completed their education in organic chemistry with a focus on doctoral research. Adam obtained a Post-Doctoral Research degree at Stanford University from 1999 to 2000. Prior to that, they pursued an extensive academic path at the University of Nottingham. From 1992 to 1998, they achieved a 1st Class BSc degree in Chemistry and Organic Chemistry, culminating in a PhD.